Catyalyst Pharmaceutical (CPRX) Posts Narrower than Expected Q2 Loss of 1c/Share
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.38 -0.06%
EPS Growth %: -30.9%
Financial Fact:
Loss from operations: -3.91M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -30.9%
Financial Fact:
Loss from operations: -3.91M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Catyalyst Pharmaceutical Partners (NASDAQ: CPRX) reported Q2 EPS of ($0.01), $0.04 better than the analyst estimate of ($0.05).
For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.
For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Stifel downgrades Intuit to Hold on growth concerns, cuts target price
- Pfizer reaffirms 2026 guidance after CFO transition news
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
